Journal of Clinical Oncology· 2019Q1· Clinical trial

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer, Kari Bohlke et al.

1,485citations
Q1SCImago
2019year

Short summary

Updated ASCO guidelines recommend offering thromboprophylaxis with apixaban, rivaroxaban, or LMWH to selected high-risk cancer outpatients, and add rivaroxaban and edoxaban as options for VTE treatment.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Internal Medicine

Internal MedicineMedicine